The company said the divestiture of its medical imaging business in the fourth quarter reduced revenues to below previous guidance.
The bank rated companies like Thermo Fisher Scientific and Agilent at Buy, Illumina and PerkinElmer at Hold, and Myriad Genetics and Luminex at Sell.
The agreement with PerkinElmer's Wallac Oy subsidiary will bring Mobidiag's real-time PCR-based gastrointestinal tests to a new market.
Executives provided updates on their companies at the 35th Annual JP Morgan Healthcare Conference in San Francisco.
Tulip Diagnostics Private provides in vitro diagnostic reagents, kits, and instruments to labs, and government and private healthcare facilities in India.
The companies will merge 10x's Chromium system and PerkinElmer's automation solutions into a combined NGS solution for researchers.
The company said the divestiture to Varian Medical Systems would allow it to concentrate on investing in high-growth parts of its business.
The company reported drops in revenues for both its human health and environmental health units, blaming challenging market conditions for the decreases.
Several academic and commercial groups are developing clinical cell-based noninvasive prenatal tests, which could eventually compete with current cell-free NIPTs.
The company said the diagnostics unit will be focused on reproductive health, diagnostics for emerging markets, and applied genomics.
In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.
An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.
The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.
For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.